Clinical Trial Update: Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of RNS60 on the late-phase asthmatic response to allergen challenge in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Asthma | Phase 2 | Status: COMPLETED